Last Updated: 9 April 2025

Agilisium, a data innovation and AI partner for the life sciences industry, has launched its domain-trained Insight Generation AI Agent, developed specifically to support decision-making across the entire life sciences value chain.
Unlike generic platforms, this AI agent is a configurable intelligence layer that adapts to the unique challenges within the sector.
It helps teams extract insights from both structured and unstructured data. From identifying signals in R&D to summarizing real-world evidence and managing HCP engagement data, it enables business users to develop their own use cases with minimal technical involvement.
The new solution stands out with its industry-specific design. Agilisium’s AI agent supports natural language queries and processes multi-modal data, seamlessly integrating with enterprise platforms like Veeva, Snowflake, and Databricks.
Among its key capabilities:
This allows scientists, marketers, and operations leaders to act quickly, using evidence-backed insights without needing to wait for analytics cycles.
"This is more than just a product launch—it's a shift in how life sciences organizations engage with their own data. Our Insight Generation Agent is not only trained to understand data, but the domain context too—delivering high-quality answers and decision support without the latency of traditional analytics cycles."
Raj Babu, Founder & CEO Agilisium
Agilisium’s credibility in the space is supported by several key recognitions:
"At Agilisium, we believe insight generation & consumption shouldn't be limited to engineers and analyst. This agent enables & empowers business—scientists, marketers, operations leaders—anyone looking to move faster with confidence, grounded in evidence."
Arun Kumar, Global CTO, Agilisium
Additionally, Agilisium’s GenAI Agents are transforming operations at 7 of the top 10 Fortune 500 and Global 2000 pharma companies.
Agilisium is a leading data innovation partner for the life sciences industry. The company works with top pharma and biotech firms to deliver insights and solutions that span drug discovery, patient care, commercial success, product delivery, and collaboration.
By combining deep domain expertise with cloud, generative AI, and advanced analytics, Agilisium helps organizations turn data into decisions—faster, smarter, and with greater impact.